Dose-dependent role of novel agents emodin and BTB14431 in colonic cancer treatment in rats.

Chris BraumannGerold KoplinCaroline GeierPhilipp HöhnJana PohlenzWolfgang DubielStephan Rogalla

Published in: Acta chirurgica Belgica (2017)

Apoptosis was verified but no tumor-suppressing effects could be observed for iv and ip treatment with both agents in contrast to in vitro studies in our model. Establishing a successful ip treatment model for emotion and BTB14331 requires further studies.

Keyphrases

cell death
depressive symptoms
case control
combination therapy
ulcerative colitis
contrast enhanced